Jay Rughani

Guests Julie Yoo and Jay Rughani from a16z Bio + Health discuss AI adoption in healthcare with executives, covering topics like improving efficiency, patient messaging, measuring tech ROI, navigating adoption challenges, and building strategic partnerships.

Jay Rughani, a bio market development partner, dives into the complexities of drug pricing, illustrating why it's so difficult to navigate. He discusses recent bipartisan proposals aimed at capping costs for seniors while highlighting the roles of stakeholders, like Pharmacy Benefit Managers, in this intricate landscape. Additionally, mobile malware, particularly a new variant named Monocle, is examined, emphasizing the unique security challenges it poses for mobile devices in today's digital environment.